SHPMY (Shanghai Pharmaceuticals Holding Co) Cyclically Adjusted FCF per Share: $0.26 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHPMY Shanghai Pharmaceuticals Holding Co Ltd SHPMY
81 GF Score
Price $7.34
GF Value $8.83
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Cyclically Adjusted FCF per Share?

Shanghai Pharmaceuticals Holding Co SHPMY -3.42% 81 Cyclically Adjusted FCF per Share is $0.26 as of Mar. 2026. GuruFocus rates SHPMY with a GF Score™ of 81/100 and a GF Value™ of $8.83 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.330. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.26 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average Cyclically Adjusted FCF Growth Rate was 28.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 11.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Shanghai Pharmaceuticals Holding Co was 20.00% per year. The lowest was -15.80% per year. And the median was 5.90% per year.

As of today (2026-07-14), Shanghai Pharmaceuticals Holding Co's current stock price is $7.3398. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $0.26. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF of today is 28.23.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shanghai Pharmaceuticals Holding Co was 92.46. The lowest was 25.92. And the median was 54.00.


Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=7.3398/0.26
=28.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shanghai Pharmaceuticals Holding Co was 92.46. The lowest was 25.92. And the median was 54.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted FCF per Share Related Terms


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted FCF per Share Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.17 0.18 0.20 0.29

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.20 0.25 0.29 0.26

SHPMY vs MCK, CAH, COR: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF falls into.


SHPMY
81GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Pharmaceuticals Holding Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.33/116.3033*116.3033
=-0.330

Current CPI (Mar. 2026) = 116.3033.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.031 101.400 0.036
201609 -0.016 102.400 -0.018
201612 -0.045 102.600 -0.051
201703 -0.010 103.200 -0.011
201706 0.090 103.100 0.102
201709 0.031 104.100 0.035
201712 0.068 104.500 0.076
201803 -0.103 105.300 -0.114
201806 0.144 104.900 0.160
201809 0.064 106.600 0.070
201812 0.198 106.500 0.216
201903 -0.069 107.700 -0.075
201906 0.350 107.700 0.378
201909 0.027 109.800 0.029
201912 0.507 111.200 0.530
202003 -0.339 112.300 -0.351
202006 0.817 110.400 0.861
202009 0.253 111.700 0.263
202012 0.231 111.500 0.241
202103 -0.457 112.662 -0.472
202106 0.742 111.769 0.772
202109 0.033 112.215 0.034
202112 -0.055 113.108 -0.057
202203 -0.851 114.335 -0.866
202206 0.301 114.558 0.306
202209 -0.111 115.339 -0.112
202212 0.749 115.116 0.757
202303 -0.650 115.116 -0.657
202306 0.660 114.558 0.670
202309 -0.022 115.339 -0.022
202312 0.422 114.781 0.428
202403 -1.200 115.227 -1.211
202406 0.998 114.781 1.011
202409 0.348 115.785 0.350
202412 0.467 114.893 0.473
202503 -0.547 115.116 -0.553
202506 0.523 114.907 0.529
202509 0.167 115.471 0.168
202512 0.584 115.832 0.586
202603 -0.330 116.303 -0.330

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.26 mean?
Shanghai Pharmaceuticals Holding Co (SHPMY) has a Cyclically Adjusted FCF per Share of $0.26 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted FCF per Share too high?
Shanghai Pharmaceuticals Holding Co's current Cyclically Adjusted FCF per Share is $0.26. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted FCF per Share compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted FCF per Share of $0.26 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Cyclically Adjusted FCF per Share is $0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co (SHPMY) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.83, compared to a current price of $7.34 — trading 16.9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.26. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMY), the current Cyclically Adjusted FCF per Share is $0.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMY) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $7.34 is trading 16.9% below its estimated GF Value™ of $8.83. GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.

Key valuation signals for SHPMY:

  • Cyclically Adjusted FCF per Share: $0.26
  • GF Value™: $8.83 vs. price of $7.34 (16.9% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the SHPMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
81GF Score

Get the complete analysis for SHPMY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.34
Price
$8.83
GF Value